Laura is the vice president of content for The American Journal of Managed Care® (AJMC®) and all its brands, including The American Journal of Accountable Care®, Evidence-Based Oncology™, and The Center for Biosimilars®. She has been working on AJMC® since 2014 and has been with AJMC®’s parent company, MJH Life Sciences®, since 2011.
She has an MA in business and economic reporting from New York University. You can connect with Laura on LinkedIn or Twitter.
Validated Measure Assesses the Impact of Treatment for Growth Hormone Deficiency in Children
November 6th 2021A validation of the observer-reported outcome of the Growth Hormone Deficiency-Child Impact Measure found it valid and reliable to understand the impact of treatment with growth hormone therapy.
Patients With CTEPH Have Worse Baseline HRQOL Than Patients With IPAH
November 6th 2021At baseline, patients with chronic thromboembolic pulmonary hypertension (CTEPH) had worse health-related quality of life (HRQOL) than patients with idiopathic pulmonary arterial hypertension (IPAH), but over time the scores were similar.
Children With HCC Have Higher Waitlist Mortality for Liver Transplant Than Children With HBL
November 5th 2021The higher waitlist mortality for liver transplant among children with hepatocellular carcinoma (HCC) compared with hepatoblastoma (HBL) indicates a need to improve prioritization for children with HCC.
Comparing Costs and HRU for Tisagenlecleucel vs Axicabtagene Ciloleucel for DLBCL
October 25th 2021Posters presented at AMCP Nexus 2021 evaluated the health care resource utilization (HRU) and costs associated with the chimeric antigen receptor T-cell therapies tisagenlecleucel and axicabtagene ciloleucel.
Asembia 2021 Is Looking to the Future of Specialty Pharmacy
October 22nd 2021At the fully in-person meeting of the Asembia 2021 Specialty Pharmacy Summit, held in Las Vegas, Nevada, attendees will get multiple sessions looking into the future of specialty pharmacy, as well as sessions on hot topics like telehealth and health equity.
What's Next After OCM? Possibly a Gap and Something Mandatory, Experts Predict
September 25th 2021With the Oncology Care Model (OCM) slated to end in 2022, the successor model is still not in place. According to panelists, there is likely going to be a gap after OCM ends and the new model begins, but more importantly, practices should prepare for the new model to be mandatory.
Addressing Disparities Starts With Engaging the Community
September 24th 2021In the opening sessions at the Patient-Centered Oncology Care® conference, held September 23-24 both virtually and in Nashville, Tennessee, speakers focused on addressing disparities by getting involved and engaged with the community.
FDA Committee Votes Against COVID-19 Vaccine Booster for General Population
September 17th 2021The advisory committee voted against COVID-19 vaccine booster shots for individuals 16 years and older, but unanimously voted for booster shots for people 65 years and older or who are at high risk of severe COVID-19.
Posters Highlight Need for Psychosocial Support in Adolescent Survivors of Childhood Leukemia
September 14th 2021Two posters being presented at the European Society for Medical Oncology Congress 2021 highlighted the need to provide long-term psychosocial support for adolescents who survive childhood leukemia.
The Green Environment, Air Pollution, and Respiratory Health
September 9th 2021Increasing air pollution and climate change have an impact on respiratory health and mortality, explained speakers in 2 sessions on the environment and respiratory diseases at the European Respiratory Society International Congress 2021.